Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Humana Inc Stock Research

HUM

484.72USD+10.92(+2.30%)Market Closed
Watchlist

Market Summary

USD484.72+10.92
Market Closed
2.30%

HUM Alerts

  • Big jump in Earnings (Y/Y)

HUM Stock Price

HUM RSI Chart

HUM Valuation

Market Cap

65.7B

Price/Earnings (Trailing)

23.41

Price/Sales (Trailing)

0.71

EV/EBITDA

12.85

Price/Free Cashflow

18.95

HUM Price/Sales (Trailing)

HUM Profitability

EBT Margin

4.14%

Return on Equity

18.79%

Return on Assets

5.69%

Free Cashflow Yield

5.28%

HUM Fundamentals

HUM Revenue

Revenue (TTM)

98.7B

Revenue Y/Y

13.04%

Revenue Q/Q

0.02%

HUM Earnings

Earnings (TTM)

3.4B

Earnings Y/Y

37.79%

Earnings Q/Q

-22.6%

Price Action

52 Week Range

423.29571.30
(Low)(High)

Last 7 days

1.0%

Last 30 days

-3.4%

Last 90 days

4.7%

Trailing 12 Months

-5.4%

HUM Financial Health

Current Ratio

1.39

HUM Investor Care

Diluted EPS (TTM)

26.84

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for HUM

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-08-01
Diamond Susan M
sold (taxes)
-66,429
458
-145
chief financial officer
2023-08-01
Felter John-Paul W.
sold (taxes)
-29,778
458
-65.00
svp, chief accting off & cont.
2023-08-01
Felter John-Paul W.
acquired
-
-
210
svp, chief accting off & cont.
2023-08-01
Diamond Susan M
acquired
-
-
311
chief financial officer
2023-05-05
Diamond Susan M
sold
-
-
-700
chief financial officer
2023-05-04
Diamond Susan M
acquired
1,220,740
362
3,369
chief financial officer
2023-05-04
Diamond Susan M
gifted
-
-
-100
chief financial officer
2023-05-04
Diamond Susan M
sold
-2,187,230
526
-4,156
chief financial officer
2023-03-01
Feinberg David T
acquired
-
-
441
-
2023-02-28
JONES DAVID A JR/KY
gifted
-
-
-10,000
-

1–10 of 50

Which funds bought or sold HUM recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-12
Farther Finance Advisors, LLC
reduced
-28.66
-579,138
1,109,780
0.24%
2023-09-05
Delos Wealth Advisors, LLC
unchanged
-
-38.00
448
-%
2023-09-05
Covenant Partners, LLC
unchanged
-
-21,465
250,393
0.09%
2023-09-01
Portside Wealth Group, LLC
new
-
785,628
785,628
0.15%
2023-08-28
Banco BTG Pactual S.A.
new
-
869,220
869,220
0.17%
2023-08-24
Alberta Investment Management Corp
added
66.28
3,165,380
9,121,000
0.09%
2023-08-23
Stonebridge Capital Advisors LLC
sold off
-100
-3,398
-
-%
2023-08-23
WOLVERINE TRADING, LLC
new
-
937,876
937,876
-%
2023-08-22
Segment Wealth Management, LLC
unchanged
-
-33,654
392,580
0.04%
2023-08-22
Old North State Trust, LLC
sold off
-100
-75,000
-
-%

1–10 of 45

Latest Funds Activity

Are funds buying HUM calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own HUM
No. of Funds

Schedule 13G FIlings of Humana

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
price t rowe associates inc /md/
6.0%
7,623,150
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
8.97%
11,357,974
SC 13G/A
Feb 06, 2023
wellington management group llp
6.01%
7,611,181
SC 13G
Jan 25, 2023
blackrock inc.
9.2%
11,628,073
SC 13G/A
Jun 09, 2022
blackrock inc.
10.1%
12,733,508
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
8.1%
10,508,002
SC 13G/A
Feb 10, 2022
vanguard group inc
7.79%
10,008,322
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G/A
Feb 01, 2022
blackrock inc.
8.8%
11,254,355
SC 13G/A

Recent SEC filings of Humana

View All Filings
Date Filed Form Type Document
Sep 19, 2023
4
Insider Trading
Sep 06, 2023
8-K
Current Report
Aug 21, 2023
8-K
Current Report
Aug 03, 2023
4
Insider Trading
Aug 03, 2023
4
Insider Trading
Aug 02, 2023
8-K
Current Report
Aug 02, 2023
10-Q
Quarterly Report
Jul 05, 2023
4
Insider Trading
Jul 05, 2023
4
Insider Trading
Jul 05, 2023
4
Insider Trading

Peers (Alternatives to Humana)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
445.6B
348.5B
-3.57% -7.58%
21.11
1.28
13.69% 15.63%
91.1B
186.1B
3.13% -0.86%
13.64
1.92
3.72% 22.38%
65.7B
98.7B
-3.38% -5.44%
23.41
0.71
10.45% 7.48%
37.0B
147.9B
6.51% -19.96%
13.66
0.25
7.12% 45.86%
MID-CAP
6.1B
937.9M
5.74% -1.29%
473.62
6.48
17.97% 120.64%
5.2B
2.3B
3.17% 35.63%
86.23
2.28
2.85% -58.05%
3.4B
732.5M
-11.21% 29.57%
48.43
4.59
9.34% 4.86%
3.3B
4.4B
-1.92% -18.46%
10.4
0.76
-16.06% -30.43%
2.8B
6.5B
-15.03% 11.13%
13.03
0.43
1.83% 10.70%
SMALL-CAP
1.9B
1.5B
-5.48% 41.28%
-147.37
1.24
12.20% -155.34%
1.4B
999.1M
-8.19% -9.37%
25.2
1.36
10.42% 21.37%
779.3M
3.0B
-0.48% -21.89%
-7.56
0.26
11.66% -12.20%

Humana News

Nasdaq
Humana (HUM) Stock Moves -0.05%: What You Should Know.
Nasdaq,
23 hours ago
InvestorsObserver
Yahoo Finance

Returns for HUM

Cumulative Returns on HUM

18.1%


10-Year Cumulative Returns

16.0%


7-Year Cumulative Returns

7.6%


5-Year Cumulative Returns

6.0%


3-Year Cumulative Returns

Risks for HUM

What is the probability of a big loss on HUM?

63.1%


Probability that Humana stock will be more than 20% underwater in next one year

19.2%


Probability that Humana stock will be more than 30% underwater in next one year.

0%


Probability that Humana stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does HUM drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Humana was unfortunately bought at previous high price.

Drawdowns

Financials for Humana

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue3.2%98,72795,64292,87091,48589,38386,36683,06481,07280,45078,88877,15574,38870,55467,71664,88862,76160,72658,74056,91255,93355,009
  S&GA Expenses-0.5%12,70212,76412,67112,51512,05711,00010,1219,7949,7049,94210,0529,1138,4897,8387,3817,3677,3787,4367,5257,2837,071
EBITDA-100.0%-5,1544,7184,6904,9894,5904,3853,9444,0485,7975,4536,4845,5704,1844,2104,0544,0362,7942,7342,7982,683
EBITDA Margin-100.0%-0.05*0.05*0.05*0.06*0.05*0.05*0.05*0.05*0.07*0.07*0.09*0.08*0.06*0.06*0.06*0.07*0.05*0.05*0.05*0.05*
Interest Expenses4.5%443424401384370348326307294291283269256240242243234227218235241
Earnings Before Taxes3.5%4,1023,9623,5683,5793,9183,5343,3542,9563,0754,9234,6005,6514,7843,4273,4563,2993,3122,1022,0632,1172,015
EBT Margin-100.0%-0.04*0.04*0.04*0.05*0.04*0.04*0.04*0.04*0.06*0.06*0.08*0.07*0.05*0.05*0.05*0.05*0.04*0.04*0.04*0.04*
Net Income8.4%3,3783,1152,8062,8073,1433,0352,9332,6732,4823,7223,3674,1533,5022,6142,7072,5502,5051,7581,6831,5121,367
Net Income Margin-100.0%-0.03*0.03*0.03*0.04*0.04*0.04*0.03*0.03*0.05*0.04*0.06*0.05*0.04*0.04*0.04*0.04*0.03*0.03*0.03*0.02*
Free Cashflow-100.0%-9,9243,4678,3852,7292,0809461,4004563,2664,6754,9705,6374,0734,5483,757306-1,2341,561-9892,950
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets3.1%56,45554,77643,05550,76546,82046,30844,35845,32038,07037,41534,96938,47738,45534,63329,07429,18028,91328,34925,41327,49034,270
  Current Assets3.3%38,75937,53226,18333,71127,21726,84024,89325,81525,79025,52623,64127,03127,86824,55119,88820,32420,16019,67316,94819,07726,864
    Cash Equivalents18.0%16,21413,7355,06113,5585,2204,8643,3944,3043,3783,8774,6737,9857,1636,0544,0545,5274,7783,8772,3434,1428,831
  Net PPE2.3%3,3093,2343,2213,2183,1213,1893,0732,8982,6902,5072,3712,2282,1182,0231,9551,8641,7961,7541,7351,6851,626
  Goodwill2.3%9,5399,3209,1429,0968,91111,13911,09210,8064,9144,6024,4474,4434,4434,4433,9283,9223,9223,8973,8973,8953,895
Liabilities3.7%39,56438,14227,68534,44831,31030,96628,25529,03823,22723,22521,24122,70924,03922,27817,03717,57917,04117,50815,25216,89724,059
  Current Liabilities5.0%28,27926,94217,17825,05117,83917,53215,33115,02715,05115,30013,39414,90516,45514,83010,92911,10611,53911,92710,07711,32418,768
  Short Term Borrowings-------------------1,694398398
    LT Debt, Non Current-0.2%9,7229,7439,0347,79811,29011,28510,54111,4666,0636,0626,0606,0596,0586,0574,9675,3654,3774,3764,3754,7744,773
Shareholder's Equity1.2%16,83416,63415,31116,31715,51015,34216,10316,28214,84314,19013,72815,76814,41612,35512,03711,60111,87210,84110,16110,59310,211
  Retained Earnings3.2%27,46826,61925,49225,60624,51123,91523,08623,19121,75121,25220,51720,87219,61617,87117,48317,04516,42915,56315,07214,78614,211
  Additional Paid-In Capital1.6%3,3133,2623,2463,2343,1533,1033,0823,0643,0182,7122,7052,9402,8982,8572,8202,6082,7632,7222,5352,7072,672
Minority Interest0%57.0057.0059.0063.0020.0023.0023.0022.00-------------
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations20.2%13,18910,9724,5879,6184,0003,4012,2622,6411,6214,3285,6395,8686,4954,8625,2844,439942-6172,173-4053,513
  Share Based Compensation0.5%212211216221189184180184183184181173169166163151144135137146143
Cashflow From Investing17.5%-1,361-1,650-1,006-96.00-6,023-5,716-6,556-6,509-2,406-3,343-3,065-3,811-4,229-2,633-1,278-924-2,711-2,537-3,087-3,805-2,150
Cashflow From Financing-84.9%-834-451-1,914-2683,8653,3023,015187-3,000-3,162-1,955401119-52.00-2,295-2,130-2,284-1,824-785-1,513-671
  Dividend Payments2.7%412401392382372362354347340333323314305296291286281276265253242
  Buy Backs45.0%1,6911,1662,0961,0751,0741,07379.001,8261,8281,8331,82090.001,0851,0771,0701,8061,0071,0491,0901,8401,880

HUM Income Statement

2023-06-30
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)
$ in Millions
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]Health Care [Member]Health Care [Member]Health Care [Member]Health Care [Member]
Revenues:    
Premiums$ 25,495$ 22,266$ 51,045$ 44,969
Services9781,3491,9772,613
Investment income2744746750
Total revenues26,74723,66253,48947,632
Operating expenses:    
Benefits22,00919,09943,86738,724
Operating costs3,1113,1736,0906,059
Depreciation and amortization191175377345
Total operating expenses25,31122,44750,33445,128
Income (loss) from operations1,4361,2153,1552,504
Interest expense120101233191
Other expense (income), net54(8)46(29)
Income before income taxes and equity in net losses1,2621,1222,8762,342
Provision for income taxes296427655713
Equity in net (losses) earnings(10)2(27)(2)
Net income9566972,1941,627
Net loss (income) attributable to noncontrolling interests3(1)4(1)
Net income attributable to Humana$ 959$ 696$ 2,198$ 1,626
Basic earnings per common share (in dollars per share)$ 7.70$ 5.50$ 17.62$ 12.83
Diluted earnings per common share (in dollars per share)$ 7.66$ 5.48$ 17.54$ 12.77

HUM Balance Sheet

2023-06-30
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 16,214$ 5,061
Investment securities15,25113,881
Receivables, net of allowances of $72 in 2023 and $70 in 20221,4291,674
Other current assets5,8655,567
Total current assets38,75926,183
Property and equipment, net3,3093,221
Long-term investment securities389380
Equity method investments733749
Goodwill9,5399,142
Other long-term assets3,7263,380
Total assets56,45543,055
Current liabilities:  
Benefits payable10,3049,264
Trade accounts payable and accrued expenses8,1185,238
Book overdraft457298
Unearned revenues7,378286
Short-term debt2,0222,092
Total current liabilities28,27917,178
Long-term debt9,7229,034
Other long-term liabilities1,5631,473
Total liabilities39,56427,685
Stockholders’ equity:  
Preferred stock, $1 par; 10,000,000 shares authorized; none issued00
Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,690,082 shares issued at June 30, 2023 and 198,666,598 shares issued at December 31, 20223333
Capital in excess of par value3,3133,246
Retained earnings27,46825,492
Accumulated other comprehensive loss(1,226)(1,304)
Treasury stock, at cost, 74,783,332 shares at June 30, 2023 and 73,691,955 shares at December 31, 2022(12,754)(12,156)
Total stockholders' equity16,83415,311
Noncontrolling interests5759
Total equity16,89115,370
Total liabilities and equity$ 56,455$ 43,055
Bruce D. Broussard
65535
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.